Procedures designed to prevent microbiological contamination of drug products purporting to be sterile did not include adequate validation of the aseptic process.
Inspection Record
Apotek Production & Laboratorier AB — FDA 483 Findings
Inspectors Anastasia M ShieldsThe inspectors who signed the published document.Inspector lookup
View the regulator's official source The source document is always the basis for judgement.
Findings
Laboratory controls do not include the establishment of scientifically sound and appropriate test procedures designed to assure that drug products conform to appropriate standards of identity, strength, quality and purity.
Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design and suitably located to facilitate operations for its intended use.
Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
Your firm failed to establish adequate written procedures for production and process controls designed to assure that the drug products have the identity, strength, purity, and quality that they are purported or represented to possess.
Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are instituted only by authorized personnel.
The batch production and control records are deficient in that they do not include documentation of the accomplishment of each significant step in manufacturing and processing.
Aseptic processing areas are deficient regarding the system for monitoring environmental conditions.
Each batch of drug product purporting to be sterile and pyrogen-free is not laboratory tested to determine conformance to such requirements.
Similar findings at other companies
GRM selected findings from the same type of public document whose wording is close to a finding in this document. One per company.
- Shilpa Medicare Limited2026-05-29 · US FDASimilar to finding 6 Appropriate controls are not exercised over computers or related systems to assure that changes in master production and control records or other records are…
- TAILSTORM HEALTH INC2026-08-28 · US FDASimilar to finding 4 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
- Jiangsu Hansoh Pharmaceutical Group Co Ltd.2026-04-24 · US FDASimilar to finding 8 Aseptic processing areas -ate deficient regarding the system for monitoring environmental conditions.
- Coastal Meds, LLC.2015-11-07 · US FDASimilar to finding 4 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written, and followed.
- Fallon Wellness Pharmacy LLC2017-02-28 · US FDASimilar to finding 4 Procedures designed to prevent microbiological contamination of drug products purporting to be sterile are not established, written and followed.
A record as of the US FDA document published on 2026-10-22. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.